Ariad files counter claim over patent (BusinessWeek)

Ariad files counter claim over patent (BusinessWeek)
Ariad Pharmaceuticals Inc. said late Friday it filed a counter claim against Amgen Inc. over the patent to methods of treating human disease by regulating NF-(kappa)B cell-signaling activity.